Holley-Cotec Pharmaceuticals

Holley-Cotec Pharmaceuticals is a prominent Chinese pharmaceutical firm specializing in the research, manufacture, and international distribution of artemisinin-based antimalarial drugs. A key subsidiary of the Holley Group, the company is best known for its flagship product Cotecxin (dihydroartemisinin), which was one of the first artemisinin derivatives to be commercialized globally. Holley-Cotec operates a comprehensive supply chain that includes the cultivation of Artemisia annua, extraction of active ingredients, and production of finished oral medications. The company maintains a strong presence in African and Southeast Asian markets, collaborating with international health organizations to combat malaria. Beyond its core antimalarial portfolio, the company leverages its expertise in traditional Chinese medicine derivatives to explore treatments for other infectious and chronic diseases.